For the Inventor, By the Inventor

Enter inventor name

San Diego, CA, United States of America

Zhenwei Miao

This inventor holds 50 USPTO granted patents and 13 published patent applications, plus 7 CIPO patents and 17 EPO patents, primarily in Drug-Conjugates. Top assignees: Ambrx, Inc., Enanta Pharmaceuticals, Inc., Concortis Biosystems, Corp.. Active years: 2006-2026.

USPTO Granted Patents = 50 (Patent Applications = 13)

% Patents Active = 68.0

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 17 (Patent Applications = 15)

Average Co-Inventor Count = 4.4

ph-index = 17

Forward Citations = 699(Granted Patents)

Location History:

Medway, MA (US) (2006 - 2010)
San Diego, CA (US) (2007 - 2024)

Company Filing History:

Enanta Pharmaceuticals, Inc.

Concortis Biosystems, Corp.

4. 2 out of 114

Sorrento Therapeutics, Inc.

Concortis Biosystems, Corp., a Wholly Owned Subsidiary of Sorrento Therapeutics, Inc.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

10. 1 out of 834,350

Other

patents

Years Active: 2006-2026

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Drug-Conjugates

Antibody-Drug Conjugates

Non-Natural Amino Acids

Polypeptides

Conjugation Methods

Hepatitis C Inhibitors

Dolastatin Derivatives

Modified Insulin Polypeptides

Targeting Molecules

Preparation Methods

Composition Uses

Accelerants

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622944 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2026-05-12),

2. 12115228 - Drug-conjugates, conjugation methods, and uses thereof (2024-10-15),

3. 11987622 - Drug-conjugates with a targeting molecule and two different drugs (2024-05-21),

4. 11903948 - Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof (2024-02-20),

5. 11420999 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2022-08-23),

6. 10967071 - Drug-conjugates, conjugation methods, and uses thereof (2021-04-06),

7. 10954270 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2021-03-23),

8. 10836821 - Drug-conjugates with a targeting molecule and two different drugs (2020-11-17),

9. 10590165 - Antibody drug conjugates (2020-03-17),

10. 9981046 - Drug-conjugates, conjugation methods, and uses thereof (2018-05-29),

11. 9884127 - Drug-conjugates, conjugation methods, and uses thereof (2018-02-06),

12. 9801951 - Drug-conjugates, conjugation methods, and uses thereof (2017-10-31),

13. 9796754 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2017-10-24),

14. 9637441 - Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides (2017-05-02),

15. 9586988 - Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides (2017-03-07),

Hello! How can I assist you today?

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]

Loading…